Related Experiment Video
Updated: Nov 12, 2025
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
4.6K
Drug-Induced Myelosuppression in Kidney Transplant Patients
Fedaey Abbas1,2, Mohsen El Kossi, Ihab Sakr Shaheen
1From the Jaber El Ahmed Military Hospital, Nephrology Department, Safat, Kuwait.
Summary
Kidney transplant patients can experience hematological issues like leukopenia, increasing infection risk. Managing immunosuppression is key, balancing rejection risk with recovery for better patient outcomes.
Area of Science:
- Nephrology
- Hematology
- Immunology
Background:
- Renal transplantation is the optimal treatment for end-stage kidney disease.
- Hematological complications, including anemia, leukopenia, neutropenia, and thrombocytopenia, can arise post-transplant.
- Persistent leukopenia and neutropenia elevate the risk of severe infections, including opportunistic ones.
Purpose of the Study:
- To review hematological complications following kidney transplantation.
- To discuss current management strategies and their limitations.
- To propose future directions for optimizing hematological recovery and patient survival.
Main Methods:
- Literature review of post-kidney transplant hematological complications.
- Analysis of the impact of immunosuppressive agents on myelopoiesis.
- Discussion of diagnostic challenges and therapeutic approaches.
Main Results:
- Immunosuppression reduction is the primary strategy for managing myelotoxicity but risks acute rejection.
- Identifying the specific immunosuppressive agent causing myelotoxicity is challenging, sometimes necessitating complete withdrawal.
- Early detection and treatment of infections are crucial.
Conclusions:
- Future strategies should prioritize minimizing immunosuppressive burden and using less myelotoxic agents.
- Optimizing myelopoietic function and normalizing hematological profiles are essential for improved allograft and patient survival.
- Integrated approaches focusing on early recognition and prompt management of infectious episodes are vital.
Related Concept Videos
01:28Kidney Transplant I: Introduction
141
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
141
01:16Kidney Transplant III: Nursing Management
152
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
152
01:26Kidney Transplant II: Surgical Procedure
138
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
138
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
130
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
130
01:11Renal Failure: Dose Adjustments
236
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
236
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
72
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
72